Corrigendum: 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3) [Ann Oncol, 28, 1, (2016), (16-33)] doi: 10.1093/annonc/mdw544

Ann Oncol 2016; 28(1): 16–33 In the original article, author F. Penault-Llorca’s name was incorrectly written as F. Pernault-Llorca. This has been corrected online. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)Annals of OncologyVol. 28Issue 1PreviewAdvanced Breast Cancer (ABC) comprises both locally advanced (LABC) and metastatic breast cancer (MBC) [1]. Although treatable, MBC remains an incurable disease with a median overall survival of ∼2–3 years and a 5-year survival of only ∼25% [2–4]. Some more recent series seem to indicate an improvement in median overall survival [5, 6]. Full-Text PDF Open Access